(Q52581027)

English

Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.

scientific article published on 6 August 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

0 references

microglial inhibitor

0 references

1 reference

based on heuristic

inferred from title

author name string

Wesolowska A

1

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

Kwiatkowska A

2

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

Slomnicki L

3

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

Dembinski M

4

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

Master A

5

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

Sliwa M

6

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

Franciszkiewicz K

7

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

Chouaib S

8

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

Kaminska B

9

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

language of work or name

0 references

publication date

6 August 2007

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

27

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

7

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

918-930

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210683

0 references

Mads and Smads in TGF beta signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Role of microglia in glioma biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

A system for stable expression of short interfering RNAs in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Inhibition of Akt kinase signalling and activation of Forkhead are indispensable for upregulation of FasL expression in apoptosis of glioma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Smads: transcriptional activators of TGF-beta responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Local gene knockdown in the brain using viral-mediated RNA interference.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Single small-interfering RNA expression vector for silencing multiple transforming growth factor-beta pathway components

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

The role of transforming growth factor beta in glioma progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

In situ detection of transforming growth factor-beta mRNA in experimental rat glioma and reactive glial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Microglia and macrophages are major sources of locally produced transforming growth factor-beta1 after transient middle cerebral artery occlusion in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Role of tumor-associated macrophages in tumor progression and invasion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Adenovirus-delivered antisense RNA and shRNA exhibit different silencing efficiencies for the endogenous transforming growth factor-beta (TGF-beta) type II receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Epidemiology and etiology of gliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Intravenous, non-viral RNAi gene therapy of brain cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Tumour-educated macrophages promote tumour progression and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Molecular mechanisms of glioma invasiveness: the role of proteases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Targeted tumor therapy with the TGF-beta 2 antisense compound AP 12009.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

The invasion promoting effect of microglia on glioblastoma cells is inhibited by cyclosporin A.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Malignant cells, directors of the malignant process: role of transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Microglia function in brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Enhanced expression of transforming growth factor‐β and its type‐I and type‐II receptors in human glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Development of TGF-beta signalling inhibitors for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Cyclosporine a induces growth arrest or programmed cell death of human glioma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

21 January 2018

Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

7 January 2021

based on heuristic

inferred from DOI database lookup

Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

7 January 2021

based on heuristic

inferred from DOI database lookup

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of transforming-growth-factor (TGF)-beta receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-beta1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210683

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1210683

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 May 2018

http://europepmc.org/abstract/MED/17684491

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52581027&oldid=1534690868"